4.6 Article

Extent of resection in patients with glioblastoma: limiting factors, perception of resectability, and effect on survival Clinical article

期刊

JOURNAL OF NEUROSURGERY
卷 117, 期 5, 页码 851-859

出版社

AMER ASSOC NEUROLOGICAL SURGEONS
DOI: 10.3171/2012.8.JNS12234

关键词

glioblastoma multiforme; resection; astrocytoma; neoplasm

向作者/读者索取更多资源

Object. The extent of resection (EOR) is a known prognostic factor in patients with glioblastoma. However, gross-total resection (GTR) is not always achieved. Understanding the factors that prevent GTR is helpful in surgical planning and when counseling patients. The goal of this study was to identify demographic, tumor-related, and technical factors that influence EOR and to define the relationship between the surgeon's impression of EOR and radiographically determined EOR. Methods. The authors performed a retrospective review of the electronic medical records to identify all patients who underwent craniotomy for glioblastoma resection between 2006 and 2009 and who had both preoperative and postoperative MRI studies. Forty-six patients were identified and were included in the study. Image analysis software (FIJI) was used to perform volumetric analysis of tumor size and EOR based on preoperative and postoperative MRI. Using multivariate analysis, the authors assessed factors associated with EOR and residual tumor volume. Perception of resectability was described using bivariate statistics, and survival was described using the log-rank test and Kaplan-Meier curves. Results. The EOR was less for tumors in eloquent areas (p = 0.014) and those touching ventricles (p = 0.031). Left parietal tumors had significantly greater residual volume (p = 0.042). The average EOR was 91.0% in this series. There was MRI-demonstrable residual tumor in 69.6% of cases (16 of 23) in which GTR was perceived by the surgeon. Expert reviewers agreed that GTR could be safely achieved in 37.0% of patients (17 of 46) in this series. Among patients with safely resectable tumors, radiographically complete resection was achieved in 23.5% of patients (4 of 17). An EOR greater than 90% was associated with a significantly greater 1-year survival (76.5%) than an EOR less than 90% (p = 0.005). Conclusions. The authors' findings confirm that tumor location affects EOR and suggest that EOR may also be influenced by the surgeon's ability to judge the presence of residual tumor during surgery. The surgeon's ability to judge completeness of resection during surgery is commonly inaccurate. The authors' study confirms the impact of EOR on 1-year survival. (http://thejns.org/doi/abs/10.3171/2012.8.JNS12234)

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Radiology, Nuclear Medicine & Medical Imaging

Newer Updates in Pediatric Vascular Diseases

Zachary M. Wilseck, Leanne Y. Lin, Neeraj Chaudhary, Francisco Rivas -Rodriguez

Summary: Pediatric neurovascular pathology refers to vascular disorders directly involving or near the central nervous system (CNS) in children. These pathologies can occur independently or in connection with broader syndromes. Imaging techniques such as ultrasound, CT, and MRI play a critical role in the diagnosis, treatment planning, and follow-up of these vascular lesions. Digital subtraction angiography (DSA) may be used as a diagnostic and therapeutic imaging method. Close collaboration between various pediatric specialists is necessary for the diagnosis and management of pediatric cerebrovascular diseases. This review provides an overview of pediatric neurovascular pathologies, presents pathognomonic imaging findings, and briefly discusses endovascular treatment options.

SEMINARS IN ROENTGENOLOGY (2023)

Editorial Material Radiology, Nuclear Medicine & Medical Imaging

MRI-visible Dilated Perivascular Spaces in the Healthy Brain

Jayapalli R. Bapuraj, Neeraj Chaudhary

RADIOLOGY (2023)

Review Clinical Neurology

Neuroendovascular Procedures in Patients with Ehlers-Danlos Type IV: Multicenter Case Series and Systematic Review

Varun Padmanaban, Patricia P. Yee, Sravanthi Koduri, Bashar Zaidat, Badih J. Daou, Neeraj Chaudhary, Joseph J. Gemmete, B. Gregory Thompson, Chris D. Kazmierczak, Kevin M. Cockroft, Aditya S. Pandey, D. Andrew Wilkinson

Summary: This study investigates the safety and efficacy of modern neuroendovascular techniques in treating cerebrovascular diseases in patients with vEDS. The evaluation of 59 patients who underwent 66 neuroendovascular procedures shows a success rate of 94%, a complication rate of 30%, and a mortality rate of 7.5%.

WORLD NEUROSURGERY (2023)

Article Ophthalmology

Comparing internal versus external carotid artery branch delivery of intraarterial chemotherapy for the treatment of retinoblastoma

Emily Chang, Yunshu Zhou, David Musch, Amy Edmonds, Laura Sedig, Raymond Hutchinson, Neeraj Chaudhary, Hakan Demirci

Summary: The purpose of this study was to compare the efficacy of intraarterial chemotherapy (IAC) for retinoblastoma delivered via the ophthalmic artery (OA) division of the internal carotid artery (ICA) versus alternative branches of the external carotid artery (ECA). The results showed that when delivery of chemotherapeutic agents via the OA is no longer feasible, the utilization of alternative routes for IAC safely allows for continuation of therapy and results in similar rates of globe salvage, reduction in tumor thickness, and reduction in basal diameter.

GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2023)

Article Endocrinology & Metabolism

Stimulated Raman histology, a novel method to allow for rapid pathologic examination of unprocessed, fresh prostate biopsies

Miles P. P. Mannas, Derek Jones, Fang-Ming Deng, Deepthi Hoskoppal, Jonathan Melamed, Daniel A. Orringer, Samir S. S. Taneja

Summary: Stimulated Raman histology (SRH) is a novel microscopic technique that provides real-time, label-free, high-resolution microscopic images of unprocessed tissue. This technology has the potential to significantly reduce the time for prostate biopsy diagnosis. The study assessed the concordance between pathologist interpretation of SRH and traditional hematoxylin and eosin (H&E) stained slides.

PROSTATE (2023)

Editorial Material Radiology, Nuclear Medicine & Medical Imaging

Insights into Middle Meningeal Artery Embolization in Chronic Subdural Hematoma: What Does Not Work

Neeraj Chaudhary, Joseph John Gemmete

RADIOLOGY (2023)

Article Clinical Neurology

Long-Term Follow-up of Multinodular and Vacuolating Neuronal Tumors and Implications for Surveillance Imaging

S. Dogra, D. Zagzag, M. Young, J. Golfinos, D. Orringer, R. Jain

Summary: This study evaluated the volume changes of MVNTs during long-term follow-up using segmentation tools and found that these tumors did not show significant changes in volume over time, suggesting that frequent surveillance imaging may not be necessary for newly diagnosed MVNTs.

AMERICAN JOURNAL OF NEURORADIOLOGY (2023)

Article Education, Scientific Disciplines

The potential of 3D models and augmented reality in teaching cross-sectional radiology

Benjamin M. Pinsky, Sreehari Panicker, Neeraj Chaudhary, Joseph J. Gemmete, Zachary M. Wilseck, Leanne Lin

Summary: The complexity and variability of cross-sectional imaging make it a challenge to teach radiologic anatomy to medical students. Recent advancements in 3D segmentation and augmented reality technology provide a promising solution by creating interactive, patient-specific 3D/AR models incorporating multiple imaging modalities.

MEDICAL TEACHER (2023)

Editorial Material Medicine, Research & Experimental

Unlocking glioma genetics with deep learning

Daniel A. Orringer, Todd C. Hollon

Summary: The AI algorithm CHARM mentioned in this issue has the potential to simplify molecular classification, intraoperative diagnosis, surgical decision making, and trial enrollment for glioma patients, thus bringing new opportunities for improving the diagnosis and treatment of human disease in the AI era.
Meeting Abstract Clinical Neurology

AI-Based Molecular Classification of Diffuse Gliomas using Rapid, Label-Free Optical Imaging

Todd Charles Hollon, John G. Golfinos, Daniel A. Orringer, Mitchel Berger, Shawn L. Hervey-Jumper, Karin M. Muraszko, Christian Freudiger, Jason Heth, Oren Sagher, Cheng Jiang, Asadur Chowdury, Mustafa Nasir Moin, Akhil Kondepudi, Alexander Arash Aabedi, Arjun R. Adapa, Wajd Al-Holou, Lisa Wadiura, Georg Widhalm, Volker Neuschmelting, David Reinecke, Sandra Camelo-Piragua

NEUROSURGERY (2023)

Article Oncology

Clinical utility of whole-genome DNA methylation profiling as a primary molecular diagnostic assay for central nervous system tumors-A prospective study and guidelines for clinical testing

Kristyn Galbraith, Varshini Vasudevaraja, Jonathan Serrano, Guomiao Shen, Ivy Tran, Nancy Abdallat, Mandisa Wen, Seema Patel, Misha Movahed-Ezazi, Arline Faustin, Marissa Spino-Keeton, Leah Geiser Roberts, Ekrem Maloku, Steven A. Drexler, Benjamin L. Liechty, David Pisapia, Olga Krasnozhen-Ratush, Marc Rosenblum, Seema Shroff, Daniel R. Boue, Christian Davidson, Qinwen Mao, Mariko Suchi, Paula North, Amanda Hopp, Annette Segura, Jason A. Jarzembowski, Lauren Parsons, Mahlon D. Johnson, Bret Mobley, Wesley Samore, Declan McGuone, Pallavi P. Gopal, Peter D. Canoll, Craig Horbinski, Joseph M. Fullmer, Midhat S. Farooqui, Murat Gokden, Nitin R. Wadhwani, Timothy E. Richardson, Melissa Umphlett, Nadejda M. Tsankova, John C. DeWitt, Chandra Sen, Dimitris G. Placantonakis, Donato Pacione, Jeffrey H. Wisoff, Eveline Teresa Hidalgo, David Harter, Christopher M. William, Christine Cordova, Sylvia C. Kurz, Marissa Barbaro, Daniel A. Orringer, Matthias A. Karajannis, Erik P. Sulman, Sharon L. Gardner, David Zagzag, Aristotelis Tsirigos, Jeffrey C. Allen, John G. Golfinos, Matija Snuderl

Summary: This study used DNA methylation analysis as a primary diagnostic method for 1921 brain tumors. The results showed that DNA methylation can provide tumor type-specific signature for diagnosis and prognostic information. This study provides a framework for inclusion of DNA methylation profiling as a primary molecular diagnostic test into professional guidelines for CNS tumors.

NEURO-ONCOLOGY ADVANCES (2023)

Meeting Abstract Oncology

Identification of Excellent Prognosis IDH Wildtype Glioblastomas Using Genomic and Metabolic Profiling

D. M. Edwards, A. Hopkins, A. Scott, R. Mannan, X. Cao, L. Zhang, A. Andren, J. A. Heth, K. Muraszko, O. Sagher, D. Orringer, T. Hollon, S. Hervey-Jumper, S. Venneti, S. Camelo-Piragua, W. Al-Holou, A. Chinnaiyan, C. A. Lyssiotis, D. R. Wahl

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2023)

Proceedings Paper Computer Science, Artificial Intelligence

Hierarchical discriminative learning improves visual representations of biomedical microscopy

Cheng Jiang, Xinhai Hou, Akhil Kondepudi, Asadur Chowdury, Christian W. Freudiger, Daniel A. Orringer, Honglak Lee, Todd C. Hollon

Summary: Learning high-quality, self-supervised, visual representations is crucial for the advancement of computer vision in biomedical microscopy and clinical medicine. HiDisc is a data-driven method that leverages the patient-slide-patch hierarchy in clinical biomedical microscopy to learn features of the underlying diagnosis. Experimental results demonstrate that HiDisc outperforms other self-supervised methods for cancer diagnosis and genetic mutation prediction, without the need for strong data augmentations.

2023 IEEE/CVF CONFERENCE ON COMPUTER VISION AND PATTERN RECOGNITION (CVPR) (2023)

Article Clinical Neurology

Association of partial T2-FLAIR mismatch sign and isocitrate dehydrogenase mutation in WHO grade 4 gliomas: results from the ReSPOND consortium

Matthew D. Lee, Sohil H. Patel, Suyash Mohan, Hamed Akbari, Spyridon Bakas, MacLean P. Nasrallah, Evan Calabrese, Jeffrey Rudie, Javier Villanueva-Meyer, Pamela LaMontagne, Daniel S. Marcus, Rivka R. Colen, Carmen Balana, Yoon Seong Choi, Chaitra Badve, Jill S. Barnholtz-Sloan, Andrew E. Sloan, Thomas C. Booth, Joshua D. Palmer, Adam P. Dicker, Adam E. Flanders, Wenyin Shi, Brent Griffith, Laila M. Poisson, Arnab Chakravarti, Abhishek Mahajan, Susan Chang, Daniel Orringer, Christos Davatzikos, Rajan Jain

Summary: The partial T2-FLAIR mismatch sign is a highly specific imaging biomarker for IDH mutation in WHO grade 4 gliomas.

NEURORADIOLOGY (2023)

Article Oncology

Combined cytotoxic and immune-stimulatory gene therapy for primary adult high-grade glioma: a phase 1, first-in- human trial

Yoshie Umemura, Daniel Orringer, Larry Junck, Maria L. Varela, Molly E. J. West, Syed M. Faisal, Andrea Comba, Jason Heth, Oren Sagher, Denise Leung, Aaron Mammoser, Shawn Hervey-Jumper, Daniel Zamler, Viveka N. Yadav, Patrick Dunn, Wajd Al-Holou, Todd Hollon, Michelle M. Kim, Daniel R. Wahl, Sandra Camelo-Piragua, Andrew P. Lieberman, Sriram Venneti, Paul Mckeever, Theodore Lawrence, Ryo Kurokawa, Karen Sagher, David Altshuler, Lili Zhao, Karin Muraszko, Maria G. Castro, Pedro Lowenstein

Summary: This study evaluated the safety and activity of two adenoviral vectors in patients with high-grade glioma. The treatment was well-tolerated and showed feasibility in patients, suggesting that further clinical trials are warranted to investigate its potential.

LANCET ONCOLOGY (2023)

暂无数据